Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 2 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
Breast Cancer Res. 2023 Jun 12;25(1):67. doi: 10.1186/s13058-023-01649-w.
Breast Cancer Res. 2023.
PMID: 37308971
Free PMC article.
Clinical Trial.
Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study.
Ruiz-Medina S, Gil S, Jimenez B, Rodriguez-Brazzarola P, Diaz-Redondo T, Cazorla M, Muñoz-Ayllon M, Ramos I, Reyna C, Bermejo MJ, Godoy A, Torres E, Cobo M, Galvez L, Rueda A, Alba E, Ribelles N.
Ruiz-Medina S, et al. Among authors: diaz redondo t.
Cancers (Basel). 2021 Jun 28;13(13):3215. doi: 10.3390/cancers13133215.
Cancers (Basel). 2021.
PMID: 34203185
Free PMC article.
Item in Clipboard
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients.
Ribelles N, Jerez JM, Rodriguez-Brazzarola P, Jimenez B, Diaz-Redondo T, Mesa H, Marquez A, Sanchez-Muñoz A, Pajares B, Carabantes F, Bermejo MJ, Villar E, Dominguez-Recio ME, Saez E, Galvez L, Godoy A, Franco L, Ruiz-Medina S, Lopez I, Alba E.
Ribelles N, et al. Among authors: diaz redondo t.
Eur J Cancer. 2021 Feb;144:224-231. doi: 10.1016/j.ejca.2020.11.030. Epub 2020 Dec 26.
Eur J Cancer. 2021.
PMID: 33373867
Item in Clipboard
Case Report: Propranolol increases the therapeutic response to temozolomide in a patient with metastatic paraganglioma.
Díaz-Castellanos MA, Gómez de Las Heras KV, Díaz-Redondo T, González-Flores E, Albiñana V, Botella LM.
Díaz-Castellanos MA, et al. Among authors: diaz redondo t.
F1000Res. 2017 Dec 4;6:2087. doi: 10.12688/f1000research.13185.1. eCollection 2017.
F1000Res. 2017.
PMID: 29527294
Free PMC article.
Item in Clipboard
ATM Variant as a Cause of Hereditary Cutaneous Melanoma in a Spanish Family: Case Report.
Lendinez-Sanchez G, Diaz-Redondo T, Campos MI, Porta Pelayo J, Porta Pelayo JM, Muriel-López C.
Lendinez-Sanchez G, et al. Among authors: diaz redondo t.
Case Rep Oncol. 2024 Feb 27;17(1):386-391. doi: 10.1159/000536105. eCollection 2024 Jan-Dec.
Case Rep Oncol. 2024.
PMID: 38415270
Free PMC article.
Item in Clipboard
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data.
Díaz-Redondo T, Lavado-Valenzuela R, Jimenez B, Pascual T, Gálvez F, Falcón A, Alamo MDC, Morales C, Amerigo M, Pascual J, Sanchez-Muñoz A, González-Guerrero M, Vicioso L, Laborda A, Ortega MV, Perez L, Fernandez-Martinez A, Chic N, Jerez JM, Alvarez M, Prat A, Ribelles N, Alba E.
Díaz-Redondo T, et al.
Front Oncol. 2019 Nov 5;9:1178. doi: 10.3389/fonc.2019.01178. eCollection 2019.
Front Oncol. 2019.
PMID: 31750258
Free PMC article.
Item in Clipboard
Cite
Cite